nodes	percent_of_prediction	percent_of_DWPC	metapath
Flecainide—CYP2D6—Fingolimod—multiple sclerosis	0.119	0.662	CbGbCtD
Flecainide—CYP2C9—Dexamethasone—multiple sclerosis	0.0317	0.176	CbGbCtD
Flecainide—CYP2D6—Dexamethasone—multiple sclerosis	0.029	0.161	CbGbCtD
Flecainide—Mefloquine—BCHE—multiple sclerosis	0.024	1	CrCbGaD
Flecainide—Eye disorder—Prednisone—multiple sclerosis	0.00095	0.00119	CcSEcCtD
Flecainide—Anxiety—Methylprednisolone—multiple sclerosis	0.000948	0.00119	CcSEcCtD
Flecainide—Rash—Azathioprine—multiple sclerosis	0.000945	0.00119	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000945	0.00119	CcSEcCtD
Flecainide—Dermatitis—Azathioprine—multiple sclerosis	0.000944	0.00119	CcSEcCtD
Flecainide—Flushing—Prednisone—multiple sclerosis	0.000943	0.00118	CcSEcCtD
Flecainide—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000943	0.00118	CcSEcCtD
Flecainide—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000943	0.00118	CcSEcCtD
Flecainide—Discomfort—Triamcinolone—multiple sclerosis	0.000942	0.00118	CcSEcCtD
Flecainide—Discomfort—Methylprednisolone—multiple sclerosis	0.00094	0.00118	CcSEcCtD
Flecainide—Headache—Azathioprine—multiple sclerosis	0.000939	0.00118	CcSEcCtD
Flecainide—Dry mouth—Triamcinolone—multiple sclerosis	0.000932	0.00117	CcSEcCtD
Flecainide—Renal failure—Methotrexate—multiple sclerosis	0.00093	0.00117	CcSEcCtD
Flecainide—Confusional state—Methylprednisolone—multiple sclerosis	0.000919	0.00115	CcSEcCtD
Flecainide—Immune system disorder—Prednisone—multiple sclerosis	0.000918	0.00115	CcSEcCtD
Flecainide—Malaise—Dexamethasone—multiple sclerosis	0.000916	0.00115	CcSEcCtD
Flecainide—Malaise—Betamethasone—multiple sclerosis	0.000916	0.00115	CcSEcCtD
Flecainide—Oedema—Triamcinolone—multiple sclerosis	0.000914	0.00115	CcSEcCtD
Flecainide—Vertigo—Dexamethasone—multiple sclerosis	0.000913	0.00115	CcSEcCtD
Flecainide—Vertigo—Betamethasone—multiple sclerosis	0.000913	0.00115	CcSEcCtD
Flecainide—Syncope—Betamethasone—multiple sclerosis	0.000911	0.00114	CcSEcCtD
Flecainide—Syncope—Dexamethasone—multiple sclerosis	0.000911	0.00114	CcSEcCtD
Flecainide—Haematuria—Methotrexate—multiple sclerosis	0.000902	0.00113	CcSEcCtD
Flecainide—Shock—Triamcinolone—multiple sclerosis	0.000899	0.00113	CcSEcCtD
Flecainide—Insomnia—Prednisolone—multiple sclerosis	0.000899	0.00113	CcSEcCtD
Flecainide—Alopecia—Prednisone—multiple sclerosis	0.000898	0.00113	CcSEcCtD
Flecainide—Shock—Methylprednisolone—multiple sclerosis	0.000897	0.00113	CcSEcCtD
Flecainide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000894	0.00112	CcSEcCtD
Flecainide—Loss of consciousness—Betamethasone—multiple sclerosis	0.000893	0.00112	CcSEcCtD
Flecainide—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000893	0.00112	CcSEcCtD
Flecainide—Paraesthesia—Prednisolone—multiple sclerosis	0.000892	0.00112	CcSEcCtD
Flecainide—Tachycardia—Triamcinolone—multiple sclerosis	0.000892	0.00112	CcSEcCtD
Flecainide—Nausea—Azathioprine—multiple sclerosis	0.00089	0.00112	CcSEcCtD
Flecainide—Tachycardia—Methylprednisolone—multiple sclerosis	0.00089	0.00112	CcSEcCtD
Flecainide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000886	0.00111	CcSEcCtD
Flecainide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000883	0.00111	CcSEcCtD
Flecainide—Agranulocytosis—Methotrexate—multiple sclerosis	0.000883	0.00111	CcSEcCtD
Flecainide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000881	0.00111	CcSEcCtD
Flecainide—Convulsion—Dexamethasone—multiple sclerosis	0.00088	0.00111	CcSEcCtD
Flecainide—Convulsion—Betamethasone—multiple sclerosis	0.00088	0.00111	CcSEcCtD
Flecainide—Hypertension—Dexamethasone—multiple sclerosis	0.000877	0.0011	CcSEcCtD
Flecainide—Hypertension—Betamethasone—multiple sclerosis	0.000877	0.0011	CcSEcCtD
Flecainide—Asthenia—Mitoxantrone—multiple sclerosis	0.000869	0.00109	CcSEcCtD
Flecainide—Myalgia—Dexamethasone—multiple sclerosis	0.000865	0.00109	CcSEcCtD
Flecainide—Myalgia—Betamethasone—multiple sclerosis	0.000865	0.00109	CcSEcCtD
Flecainide—Anxiety—Dexamethasone—multiple sclerosis	0.000862	0.00108	CcSEcCtD
Flecainide—Anxiety—Betamethasone—multiple sclerosis	0.000862	0.00108	CcSEcCtD
Flecainide—Discomfort—Dexamethasone—multiple sclerosis	0.000855	0.00107	CcSEcCtD
Flecainide—Discomfort—Betamethasone—multiple sclerosis	0.000855	0.00107	CcSEcCtD
Flecainide—Hypotension—Methylprednisolone—multiple sclerosis	0.000852	0.00107	CcSEcCtD
Flecainide—Pain—Prednisolone—multiple sclerosis	0.00085	0.00107	CcSEcCtD
Flecainide—Vision blurred—Prednisone—multiple sclerosis	0.000834	0.00105	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000833	0.00105	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000831	0.00104	CcSEcCtD
Flecainide—Oedema—Dexamethasone—multiple sclerosis	0.000829	0.00104	CcSEcCtD
Flecainide—Oedema—Betamethasone—multiple sclerosis	0.000829	0.00104	CcSEcCtD
Flecainide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000829	0.00104	CcSEcCtD
Flecainide—Insomnia—Triamcinolone—multiple sclerosis	0.000827	0.00104	CcSEcCtD
Flecainide—Insomnia—Methylprednisolone—multiple sclerosis	0.000825	0.00104	CcSEcCtD
Flecainide—Ill-defined disorder—Prednisone—multiple sclerosis	0.000821	0.00103	CcSEcCtD
Flecainide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000821	0.00103	CcSEcCtD
Flecainide—Feeling abnormal—Prednisolone—multiple sclerosis	0.000819	0.00103	CcSEcCtD
Flecainide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000819	0.00103	CcSEcCtD
Flecainide—Visual impairment—Methotrexate—multiple sclerosis	0.000819	0.00103	CcSEcCtD
Flecainide—Shock—Dexamethasone—multiple sclerosis	0.000816	0.00102	CcSEcCtD
Flecainide—Shock—Betamethasone—multiple sclerosis	0.000816	0.00102	CcSEcCtD
Flecainide—Dyspnoea—Triamcinolone—multiple sclerosis	0.000815	0.00102	CcSEcCtD
Flecainide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000813	0.00102	CcSEcCtD
Flecainide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000813	0.00102	CcSEcCtD
Flecainide—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000812	0.00102	CcSEcCtD
Flecainide—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000812	0.00102	CcSEcCtD
Flecainide—Tachycardia—Dexamethasone—multiple sclerosis	0.000809	0.00102	CcSEcCtD
Flecainide—Tachycardia—Betamethasone—multiple sclerosis	0.000809	0.00102	CcSEcCtD
Flecainide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000804	0.00101	CcSEcCtD
Flecainide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000803	0.00101	CcSEcCtD
Flecainide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000802	0.00101	CcSEcCtD
Flecainide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000802	0.00101	CcSEcCtD
Flecainide—Malaise—Prednisone—multiple sclerosis	0.000798	0.001	CcSEcCtD
Flecainide—Vertigo—Prednisone—multiple sclerosis	0.000795	0.000998	CcSEcCtD
Flecainide—Eye disorder—Methotrexate—multiple sclerosis	0.000794	0.000997	CcSEcCtD
Flecainide—Syncope—Prednisone—multiple sclerosis	0.000793	0.000996	CcSEcCtD
Flecainide—Tinnitus—Methotrexate—multiple sclerosis	0.000792	0.000994	CcSEcCtD
Flecainide—Anorexia—Betamethasone—multiple sclerosis	0.00079	0.000992	CcSEcCtD
Flecainide—Anorexia—Dexamethasone—multiple sclerosis	0.00079	0.000992	CcSEcCtD
Flecainide—Urticaria—Prednisolone—multiple sclerosis	0.000789	0.000991	CcSEcCtD
Flecainide—Fatigue—Triamcinolone—multiple sclerosis	0.000788	0.000989	CcSEcCtD
Flecainide—Fatigue—Methylprednisolone—multiple sclerosis	0.000786	0.000987	CcSEcCtD
Flecainide—Pain—Triamcinolone—multiple sclerosis	0.000781	0.000981	CcSEcCtD
Flecainide—Loss of consciousness—Prednisone—multiple sclerosis	0.000778	0.000976	CcSEcCtD
Flecainide—Hypotension—Dexamethasone—multiple sclerosis	0.000775	0.000973	CcSEcCtD
Flecainide—Hypotension—Betamethasone—multiple sclerosis	0.000775	0.000973	CcSEcCtD
Flecainide—Vomiting—Mitoxantrone—multiple sclerosis	0.00077	0.000967	CcSEcCtD
Flecainide—Immune system disorder—Methotrexate—multiple sclerosis	0.000767	0.000963	CcSEcCtD
Flecainide—Convulsion—Prednisone—multiple sclerosis	0.000767	0.000963	CcSEcCtD
Flecainide—Hypertension—Prednisone—multiple sclerosis	0.000764	0.000959	CcSEcCtD
Flecainide—Rash—Mitoxantrone—multiple sclerosis	0.000764	0.000959	CcSEcCtD
Flecainide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000763	0.000958	CcSEcCtD
Flecainide—Headache—Mitoxantrone—multiple sclerosis	0.000759	0.000953	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000755	0.000949	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000755	0.000949	CcSEcCtD
Flecainide—Myalgia—Prednisone—multiple sclerosis	0.000753	0.000946	CcSEcCtD
Flecainide—Arthralgia—Prednisone—multiple sclerosis	0.000753	0.000946	CcSEcCtD
Flecainide—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000753	0.000946	CcSEcCtD
Flecainide—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000751	0.000943	CcSEcCtD
Flecainide—Anxiety—Prednisone—multiple sclerosis	0.000751	0.000943	CcSEcCtD
Flecainide—Alopecia—Methotrexate—multiple sclerosis	0.000751	0.000943	CcSEcCtD
Flecainide—Insomnia—Dexamethasone—multiple sclerosis	0.00075	0.000942	CcSEcCtD
Flecainide—Insomnia—Betamethasone—multiple sclerosis	0.00075	0.000942	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000748	0.000939	CcSEcCtD
Flecainide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000746	0.000936	CcSEcCtD
Flecainide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000745	0.000935	CcSEcCtD
Flecainide—Paraesthesia—Betamethasone—multiple sclerosis	0.000745	0.000935	CcSEcCtD
Flecainide—Discomfort—Prednisone—multiple sclerosis	0.000744	0.000935	CcSEcCtD
Flecainide—Dyspepsia—Betamethasone—multiple sclerosis	0.00073	0.000916	CcSEcCtD
Flecainide—Dyspepsia—Dexamethasone—multiple sclerosis	0.00073	0.000916	CcSEcCtD
Flecainide—Urticaria—Triamcinolone—multiple sclerosis	0.000726	0.000912	CcSEcCtD
Flecainide—Urticaria—Methylprednisolone—multiple sclerosis	0.000724	0.00091	CcSEcCtD
Flecainide—Dysgeusia—Methotrexate—multiple sclerosis	0.000724	0.000909	CcSEcCtD
Flecainide—Body temperature increased—Triamcinolone—multiple sclerosis	0.000722	0.000907	CcSEcCtD
Flecainide—Oedema—Prednisone—multiple sclerosis	0.000722	0.000907	CcSEcCtD
Flecainide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000721	0.000905	CcSEcCtD
Flecainide—Decreased appetite—Betamethasone—multiple sclerosis	0.000721	0.000905	CcSEcCtD
Flecainide—Decreased appetite—Dexamethasone—multiple sclerosis	0.000721	0.000905	CcSEcCtD
Flecainide—Nausea—Mitoxantrone—multiple sclerosis	0.000719	0.000903	CcSEcCtD
Flecainide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000716	0.000899	CcSEcCtD
Flecainide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000716	0.000899	CcSEcCtD
Flecainide—Fatigue—Betamethasone—multiple sclerosis	0.000715	0.000898	CcSEcCtD
Flecainide—Fatigue—Dexamethasone—multiple sclerosis	0.000715	0.000898	CcSEcCtD
Flecainide—Shock—Prednisone—multiple sclerosis	0.00071	0.000892	CcSEcCtD
Flecainide—Pain—Betamethasone—multiple sclerosis	0.000709	0.00089	CcSEcCtD
Flecainide—Pain—Dexamethasone—multiple sclerosis	0.000709	0.00089	CcSEcCtD
Flecainide—Nervous system disorder—Prednisone—multiple sclerosis	0.000708	0.000889	CcSEcCtD
Flecainide—Tachycardia—Prednisone—multiple sclerosis	0.000705	0.000885	CcSEcCtD
Flecainide—Skin disorder—Prednisone—multiple sclerosis	0.000701	0.000881	CcSEcCtD
Flecainide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000698	0.000877	CcSEcCtD
Flecainide—Vision blurred—Methotrexate—multiple sclerosis	0.000697	0.000875	CcSEcCtD
Flecainide—Anorexia—Prednisone—multiple sclerosis	0.000688	0.000864	CcSEcCtD
Flecainide—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000686	0.000861	CcSEcCtD
Flecainide—Feeling abnormal—Betamethasone—multiple sclerosis	0.000683	0.000858	CcSEcCtD
Flecainide—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000683	0.000858	CcSEcCtD
Flecainide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000678	0.000851	CcSEcCtD
Flecainide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000678	0.000851	CcSEcCtD
Flecainide—Malaise—Methotrexate—multiple sclerosis	0.000667	0.000837	CcSEcCtD
Flecainide—Vertigo—Methotrexate—multiple sclerosis	0.000664	0.000834	CcSEcCtD
Flecainide—Leukopenia—Methotrexate—multiple sclerosis	0.000662	0.000831	CcSEcCtD
Flecainide—Urticaria—Dexamethasone—multiple sclerosis	0.000659	0.000827	CcSEcCtD
Flecainide—Urticaria—Betamethasone—multiple sclerosis	0.000659	0.000827	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000658	0.000826	CcSEcCtD
Flecainide—Dizziness—Prednisolone—multiple sclerosis	0.000657	0.000825	CcSEcCtD
Flecainide—Asthenia—Triamcinolone—multiple sclerosis	0.000656	0.000823	CcSEcCtD
Flecainide—Body temperature increased—Betamethasone—multiple sclerosis	0.000655	0.000823	CcSEcCtD
Flecainide—Body temperature increased—Dexamethasone—multiple sclerosis	0.000655	0.000823	CcSEcCtD
Flecainide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000655	0.000823	CcSEcCtD
Flecainide—Abdominal pain—Betamethasone—multiple sclerosis	0.000655	0.000823	CcSEcCtD
Flecainide—Asthenia—Methylprednisolone—multiple sclerosis	0.000654	0.000821	CcSEcCtD
Flecainide—Insomnia—Prednisone—multiple sclerosis	0.000653	0.00082	CcSEcCtD
Flecainide—Paraesthesia—Prednisone—multiple sclerosis	0.000648	0.000814	CcSEcCtD
Flecainide—Pruritus—Triamcinolone—multiple sclerosis	0.000647	0.000812	CcSEcCtD
Flecainide—Cough—Methotrexate—multiple sclerosis	0.000645	0.00081	CcSEcCtD
Flecainide—Pruritus—Methylprednisolone—multiple sclerosis	0.000645	0.00081	CcSEcCtD
Flecainide—Convulsion—Methotrexate—multiple sclerosis	0.000641	0.000804	CcSEcCtD
Flecainide—Dyspepsia—Prednisone—multiple sclerosis	0.000636	0.000798	CcSEcCtD
Flecainide—Arthralgia—Methotrexate—multiple sclerosis	0.00063	0.00079	CcSEcCtD
Flecainide—Myalgia—Methotrexate—multiple sclerosis	0.00063	0.00079	CcSEcCtD
Flecainide—Chest pain—Methotrexate—multiple sclerosis	0.00063	0.00079	CcSEcCtD
Flecainide—Decreased appetite—Prednisone—multiple sclerosis	0.000628	0.000788	CcSEcCtD
Flecainide—Rash—Prednisolone—multiple sclerosis	0.000627	0.000787	CcSEcCtD
Flecainide—Dermatitis—Prednisolone—multiple sclerosis	0.000626	0.000786	CcSEcCtD
Flecainide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000625	0.000785	CcSEcCtD
Flecainide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000624	0.000783	CcSEcCtD
Flecainide—Fatigue—Prednisone—multiple sclerosis	0.000623	0.000782	CcSEcCtD
Flecainide—Headache—Prednisolone—multiple sclerosis	0.000623	0.000782	CcSEcCtD
Flecainide—Discomfort—Methotrexate—multiple sclerosis	0.000622	0.000781	CcSEcCtD
Flecainide—Constipation—Prednisone—multiple sclerosis	0.000618	0.000775	CcSEcCtD
Flecainide—Confusional state—Methotrexate—multiple sclerosis	0.000608	0.000764	CcSEcCtD
Flecainide—Dizziness—Triamcinolone—multiple sclerosis	0.000604	0.000759	CcSEcCtD
Flecainide—Dizziness—Methylprednisolone—multiple sclerosis	0.000603	0.000757	CcSEcCtD
Flecainide—Feeling abnormal—Prednisone—multiple sclerosis	0.000595	0.000747	CcSEcCtD
Flecainide—Asthenia—Betamethasone—multiple sclerosis	0.000595	0.000747	CcSEcCtD
Flecainide—Asthenia—Dexamethasone—multiple sclerosis	0.000595	0.000747	CcSEcCtD
Flecainide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000592	0.000743	CcSEcCtD
Flecainide—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000591	0.000742	CcSEcCtD
Flecainide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.00059	0.000741	CcSEcCtD
Flecainide—Nausea—Prednisolone—multiple sclerosis	0.00059	0.000741	CcSEcCtD
Flecainide—Pruritus—Dexamethasone—multiple sclerosis	0.000587	0.000737	CcSEcCtD
Flecainide—Pruritus—Betamethasone—multiple sclerosis	0.000587	0.000737	CcSEcCtD
Flecainide—Skin disorder—Methotrexate—multiple sclerosis	0.000586	0.000736	CcSEcCtD
Flecainide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000583	0.000733	CcSEcCtD
Flecainide—Vomiting—Triamcinolone—multiple sclerosis	0.000581	0.00073	CcSEcCtD
Flecainide—Vomiting—Methylprednisolone—multiple sclerosis	0.00058	0.000728	CcSEcCtD
Flecainide—Rash—Triamcinolone—multiple sclerosis	0.000576	0.000723	CcSEcCtD
Flecainide—Dermatitis—Triamcinolone—multiple sclerosis	0.000576	0.000723	CcSEcCtD
Flecainide—Anorexia—Methotrexate—multiple sclerosis	0.000575	0.000722	CcSEcCtD
Flecainide—Rash—Methylprednisolone—multiple sclerosis	0.000575	0.000722	CcSEcCtD
Flecainide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000574	0.000721	CcSEcCtD
Flecainide—Urticaria—Prednisone—multiple sclerosis	0.000574	0.00072	CcSEcCtD
Flecainide—Headache—Triamcinolone—multiple sclerosis	0.000572	0.000719	CcSEcCtD
Flecainide—Headache—Methylprednisolone—multiple sclerosis	0.000571	0.000717	CcSEcCtD
Flecainide—Body temperature increased—Prednisone—multiple sclerosis	0.000571	0.000717	CcSEcCtD
Flecainide—Abdominal pain—Prednisone—multiple sclerosis	0.000571	0.000717	CcSEcCtD
Flecainide—Diarrhoea—Betamethasone—multiple sclerosis	0.000567	0.000712	CcSEcCtD
Flecainide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000567	0.000712	CcSEcCtD
Flecainide—Hypotension—Methotrexate—multiple sclerosis	0.000564	0.000708	CcSEcCtD
Flecainide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.00055	0.00069	CcSEcCtD
Flecainide—Dizziness—Betamethasone—multiple sclerosis	0.000548	0.000688	CcSEcCtD
Flecainide—Dizziness—Dexamethasone—multiple sclerosis	0.000548	0.000688	CcSEcCtD
Flecainide—Insomnia—Methotrexate—multiple sclerosis	0.000546	0.000685	CcSEcCtD
Flecainide—Nausea—Triamcinolone—multiple sclerosis	0.000543	0.000682	CcSEcCtD
Flecainide—Paraesthesia—Methotrexate—multiple sclerosis	0.000542	0.00068	CcSEcCtD
Flecainide—Nausea—Methylprednisolone—multiple sclerosis	0.000542	0.00068	CcSEcCtD
Flecainide—Dyspnoea—Methotrexate—multiple sclerosis	0.000538	0.000676	CcSEcCtD
Flecainide—Somnolence—Methotrexate—multiple sclerosis	0.000536	0.000674	CcSEcCtD
Flecainide—Dyspepsia—Methotrexate—multiple sclerosis	0.000531	0.000667	CcSEcCtD
Flecainide—Vomiting—Dexamethasone—multiple sclerosis	0.000527	0.000662	CcSEcCtD
Flecainide—Vomiting—Betamethasone—multiple sclerosis	0.000527	0.000662	CcSEcCtD
Flecainide—Decreased appetite—Methotrexate—multiple sclerosis	0.000525	0.000659	CcSEcCtD
Flecainide—Rash—Dexamethasone—multiple sclerosis	0.000523	0.000656	CcSEcCtD
Flecainide—Rash—Betamethasone—multiple sclerosis	0.000523	0.000656	CcSEcCtD
Flecainide—Dermatitis—Dexamethasone—multiple sclerosis	0.000522	0.000656	CcSEcCtD
Flecainide—Dermatitis—Betamethasone—multiple sclerosis	0.000522	0.000656	CcSEcCtD
Flecainide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000521	0.000654	CcSEcCtD
Flecainide—Fatigue—Methotrexate—multiple sclerosis	0.00052	0.000653	CcSEcCtD
Flecainide—Headache—Betamethasone—multiple sclerosis	0.000519	0.000652	CcSEcCtD
Flecainide—Headache—Dexamethasone—multiple sclerosis	0.000519	0.000652	CcSEcCtD
Flecainide—Asthenia—Prednisone—multiple sclerosis	0.000518	0.000651	CcSEcCtD
Flecainide—Pain—Methotrexate—multiple sclerosis	0.000516	0.000648	CcSEcCtD
Flecainide—Pruritus—Prednisone—multiple sclerosis	0.000511	0.000641	CcSEcCtD
Flecainide—Feeling abnormal—Methotrexate—multiple sclerosis	0.000497	0.000624	CcSEcCtD
Flecainide—Diarrhoea—Prednisone—multiple sclerosis	0.000494	0.00062	CcSEcCtD
Flecainide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000493	0.00062	CcSEcCtD
Flecainide—Nausea—Dexamethasone—multiple sclerosis	0.000493	0.000618	CcSEcCtD
Flecainide—Nausea—Betamethasone—multiple sclerosis	0.000493	0.000618	CcSEcCtD
Flecainide—Urticaria—Methotrexate—multiple sclerosis	0.000479	0.000602	CcSEcCtD
Flecainide—Dizziness—Prednisone—multiple sclerosis	0.000478	0.0006	CcSEcCtD
Flecainide—Abdominal pain—Methotrexate—multiple sclerosis	0.000477	0.000599	CcSEcCtD
Flecainide—Body temperature increased—Methotrexate—multiple sclerosis	0.000477	0.000599	CcSEcCtD
Flecainide—Vomiting—Prednisone—multiple sclerosis	0.000459	0.000576	CcSEcCtD
Flecainide—Rash—Prednisone—multiple sclerosis	0.000455	0.000572	CcSEcCtD
Flecainide—Dermatitis—Prednisone—multiple sclerosis	0.000455	0.000571	CcSEcCtD
Flecainide—Headache—Prednisone—multiple sclerosis	0.000452	0.000568	CcSEcCtD
Flecainide—Asthenia—Methotrexate—multiple sclerosis	0.000433	0.000544	CcSEcCtD
Flecainide—Nausea—Prednisone—multiple sclerosis	0.000429	0.000539	CcSEcCtD
Flecainide—Pruritus—Methotrexate—multiple sclerosis	0.000427	0.000536	CcSEcCtD
Flecainide—Diarrhoea—Methotrexate—multiple sclerosis	0.000413	0.000518	CcSEcCtD
Flecainide—Dizziness—Methotrexate—multiple sclerosis	0.000399	0.000501	CcSEcCtD
Flecainide—Vomiting—Methotrexate—multiple sclerosis	0.000384	0.000482	CcSEcCtD
Flecainide—Rash—Methotrexate—multiple sclerosis	0.000381	0.000478	CcSEcCtD
Flecainide—Dermatitis—Methotrexate—multiple sclerosis	0.00038	0.000477	CcSEcCtD
Flecainide—Headache—Methotrexate—multiple sclerosis	0.000378	0.000475	CcSEcCtD
Flecainide—Nausea—Methotrexate—multiple sclerosis	0.000358	0.00045	CcSEcCtD
